Need an oil spill lawyer? We will fight for you!
› $150,000,000 verdict in personal injury case
Johnson & Johnson, the makers of the Ortho Evra contraceptive patch for women, has agreed to settle lawsuits filed by Canadian women who suffered from blood clots, heart attacks or strokes after using the patch. The drug maker avoided trial by spending more than $68 million to settle similar claims by women in the United States, according to Bloomberg.
A new contraceptive spray currently in clinical trials is showing positive results in patients, according to Australian drug maker Acrux. The company’s Nestorone MDTS is a fourth-generation progestin contraceptive that has no androgenic hormonal effects and a good safety profile. The spray is a small, hand-held, easy-to-use spray designed to provide an easy and convenient means to deliver a preset dose of therapeutic drug directly to the skin. It is being touted by its maker as a “better choice” for women using hormonal contraceptive pills or patches.
Ortho Evra manufacturer, Johnson & Johnson, recently settled a lawsuit with the family of a 14-year-old girl killed by the defective birth control patch. The case is just one of many Ortho Evra lawsuits settled by Johnson & Johnson prior to going trial.
Johnson & Johnson agreed to pay $1.25 million to settle a lawsuit over the death of a 14-year-old girl who used the company’s Ortho Evra birth-control patch, according to court records.
![[ Beasley Allen Law Firm Logo ]](http://www.orthoevra-legal.com/wp-content/themes/system-unity/images/logo.png){kind=logo}